https://www.pharmanow.live/latest-news/granules-india-gagillapur-usfda-inspection-11-observations 2026-10-31T22:06:08+05:30 Pharma Now en 2026-10-31T00:00:00+05:30 Granules India Completes USFDA Inspection at Gagillapur with 11 Observations Issued Granules https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f12b6893-e080-4b24-bffc-537a1f942ff9/083fe18a-4053-415a-a0fa-3a4a517becff.png https://www.pharmanow.live/latest-news/zydus-appoints-christoph-stoller-president-international-markets 2026-11-02T11:48:50+05:30 Pharma Now en 2026-10-31T00:00:00+05:30 Zydus Appoints Christoph Stoller to Lead International Markets Zydus https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/zydus-christoph-stoller-president-international-markets-appointment-202620261102114612.webp https://www.pharmanow.live/latest-news/alembic-pharmaceuticals-usfda-final-approval-venetoclax-tablets-cll-sll 2026-11-02T11:37:30+05:30 Pharma Now en 2026-10-31T00:00:00+05:30 Alembic Wins USFDA Final Approval for Venetoclax in CLL/SLL Alembic https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/alembic-usfda-final-approval-venetoclax-tablets-cll-sll-202620261102113649.webp https://www.pharmanow.live/latest-news/sun-pharma-fda-approval-ilumya-sbla-psoriatic-arthritis 2026-11-02T11:27:27+05:30 Pharma Now en 2026-10-31T00:00:00+05:30 Sun Pharma Secures FDA Approval for ILUMYA in Psoriatic Arthritis Sun https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/sun-pharma-ilumya-fda-approval-psoriatic-arthritis-sbla-202620261102112523.webp https://www.pharmanow.live/latest-news/fda-digital-biomarker-validation-projects-als-cmt-huntingtons-disease 2026-11-02T11:11:56+05:30 Pharma Now en 2026-10-31T00:00:00+05:30 FDA Funds Digital Biomarker Projects in ALS, CMT and Huntington's FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-digital-biomarker-validation-als-cmt-huntingtons-disease-202620261102111103.webp https://www.pharmanow.live/latest-news/fda-approves-voceryq-first-plasmid-dna-immunotherapy-rrp 2026-11-02T11:07:15+05:30 Pharma Now en 2026-10-31T00:00:00+05:30 FDA Approves Voceryq, First Plasmid DNA Immunotherapy for RRP FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-voceryq-approval-first-plasmid-dna-immunotherapy-rrp-202620261102110654.webp https://www.pharmanow.live/latest-news/fda-updates-minocycline-susceptibility-breakpoints-stenotrophomonas-maltophilia 2026-11-02T10:57:38+05:30 Pharma Now en 2026-10-31T00:00:00+05:30 FDA Updates Minocycline Breakpoints for S. maltophilia FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-minocycline-susceptibility-breakpoints-stenotrophomonas-maltophilia-202620261102104532.webp